machine learning
Top Five Articles on 360Dx Last Week: Changes at QuidelOrtho; Diasorin Seeks FDA Clearance; More
Last week, readers were most interested in a story about QuidelOrtho's ongoing restructuring to support profitability.
The research team looked at cell-free DNA fragmentation profiles across the genome combined with measurements of two key biomarkers to detect ovarian cancer.
Cofactor Genomics Immunotherapy Response Test Nabs Medicare Coverage
The assay evaluates a patient's tumor immune profile against Cofactor's high-dimensional RNA-based Health Expression Models to predict a patient's therapy response.
The company continues to build validation data and believes its lower cost proposition can help it gain leverage in the European market where molecular tests are not reimbursed.
The test assigns a pancreatic cancer subtype based on the expression of 16 genes measured using an array.